SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Courtesy of Amgen

487

Amgen

AMGN

U.S.

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in 47 countries.

CEO

Robert A. Bradway

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Thousand Oaks, CA

Employees

17,900

Years on Global 500 List

1

Key Financials (last fiscal year)
($ Millions)% change
Revenues ($M)$21,6628.0%
Profits ($M)$6,93934.5%
Assets ($M)$71,576
Total Stockholder Equity ($M)$28,083
Profit Ratios
Profit as % of Revenues32.0%
Profits as % of Assets9.7%
Profits as % of Stockholder Equity24.7%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Amgen

Why Amgen Is Lowering the Price of Cholesterol Drug Repatha By 60%

Amgen says Repatha sold $271 million in the first half of 2018, despite earlier predictions of multi-billion-dollar sales.

Read More →
Tech's Next Big Wave: Big Data Meets Biology

Just about everyone agrees that America's health care system is broken. Is better data—and the ability to harness it—the medicine we've been looking for?

Read More →
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?

The FDA approved the first cancer medicine "biosimilar" Thursday.

Read More →